Novel therapies on the horizon for cutaneous T-cell lymphoma

1 Mga view
administrator
administrator
08/09/23

Speaking from the European Organisation for the Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Task Force (CLTF) 2018 Congress, held in St. Gallen, Switzerland, Rudolf Stadler, MD, PhD, of the University Medical Center Minden, Minden, Germany, discusses new therapy options for cutaneous T-cell lymphoma, including brentuximab vedotin and mogamulizumab. In addition, Prof. Stadler discusses promising targets for therapeutic antibodies.

  • Kategorya

Magpakita ng higit pa

0 Mga komento Pagbukud-bukurin Ayon

Walang nakitang komento

Mga Komento sa Facebook

Susunod